Skip to content
About Us
Services & Solutions
News & Resources
Catalog Product
Careers
Contact Us
Start a project

News

An invitation to the WuXi TIDES forum in London

We are pleased to invite you to the WuXi TIDES forum, titled “ Accelerating Oligonucleotide Therapeutics from Concepts to Patients “, which will be held on the pre-event day of the 10th…

Mar 16, 2023197 words

News

  • 2023-03-16

We are pleased to invite you to the WuXi TIDES forum, titled “ Accelerating Oligonucleotide Therapeutics from Concepts to Patients “, which will be held on the pre-event day of the 10th annual peptides & oligonucleotides congress.

During this forum, industry thought leaders will discuss some of the challenges that delay development at different stages and the solutions to accelerate oligonucleotide therapeutics from concept to patients. I look forward to meeting you there and at the subsequent reception dinner.

Reserve your free spot

Date: March 29 th, 2023

Forum : 13:34 – 16:45, Novotel London West

Dinner : 19:00 – 22:00, Brasserie Blanc (0.6 miles from Novotel London West)

Speakers :

  • Dr. Ekkehard Leberer, Senior Life Science Consultant, Elbionic
  • Timothy Weeden, Vice President, Head of Platform Development, Dyne Therapeutics
  • Dr. Dave Madge, Vice President, Research Services Division, WuXi AppTec
  • Dr. Pete Nguyen, Senior Director, WuXi TIDES, WuXi TIDES

Register HERE

Contact us: info@wuxitides.net

Keep reading

Related

NewsApr 1, 2025

WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections

Shanghai, China – April 1, 2025 — WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences…

Read
NewsNov 18, 2024

WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating

Couvet, Switzerland – November 14, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life…

Read
NewsNov 14, 2024

WuXi AppTec Opens New R&D Center in Changzhou, China

First operational building dedicated to API development for oligonucleotides, peptides, and complex synthetic conjugates.

Read

How can we help?

Our TIDES drug experts stand ready.

Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.

Small molecule projects? WuXi STA